Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001209191-22-037600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-16 | 2022-06-14 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +7,688 | 7,688 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | A | A | 5,197 | $0.00 | 7,291 | D | — | — | (F1) Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-14 | A | A | 7,688 | $0.00 | 7,688 | D | $38.49 · — to 2032-06-13 | 7,688 Common Stock | (F2) This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. |